84 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Article Searches
Ponce Financial (PDLB) Tops Q1 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2265526/ponce-financial-pdlb-tops-q1-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265526 Apr 30, 2024 - Ponce Financial (PDLB) delivered earnings and revenue surprises of 466.67% and 9.20%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Tops Q2 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2265516/ashland-ash-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265516 Apr 30, 2024 - Ashland (ASH) delivered earnings and revenue surprises of 6.72% and 0.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
RenaissanceRe (RNR) Tops Q1 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2265497/renaissancere-rnr-tops-q1-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265497 Apr 30, 2024 - RenaissanceRe (RNR) delivered earnings and revenue surprises of 23.53% and 5.96%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
American Assets Trust (AAT) Tops Q1 FFO and Revenue Estimates https://www.zacks.com/stock/news/2265500/american-assets-trust-aat-tops-q1-ffo-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265500 Apr 30, 2024 - American Assets Trust (AAT) delivered FFO and revenue surprises of 5.97% and 4.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2265475/lemonade-lmnd-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265475 Apr 30, 2024 - Lemonade (LMND) delivered earnings and revenue surprises of 17.28% and 5.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Root, Inc. (ROOT) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2265478/root-inc-root-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265478 Apr 30, 2024 - Root (ROOT) delivered earnings and revenue surprises of 83.27% and 37.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2265453/inari-medical-inc-nari-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265453 Apr 30, 2024 - Inari Medical (NARI) delivered earnings and revenue surprises of -136.36% and 3.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
A10 Networks (ATEN) Tops Q1 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2265459/a10-networks-aten-tops-q1-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265459 Apr 30, 2024 - A10 Networks (ATEN) delivered earnings and revenue surprises of 13.33% and 1.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Industrial Logistics Properties Trust (ILPT) Tops Q1 FFO and Revenue Estimates https://www.zacks.com/stock/news/2265460/industrial-logistics-properties-trust-ilpt-tops-q1-ffo-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265460 Apr 30, 2024 - Industrial Logistics Properties Trust (ILPT) delivered FFO and revenue surprises of 7.69% and 1.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2265431/lyra-therapeutics-inc-lyra-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2265431 Apr 30, 2024 - Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of -34.62% and 33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Pages: 123456789

<<<Page 4>